Robert Neil Goldstone, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anus Neoplasms | 3 | 2017 | 295 | 1.320 |
Why?
|
Colectomy | 6 | 2022 | 650 | 1.280 |
Why?
|
Tunica Intima | 2 | 2018 | 501 | 1.050 |
Why?
|
Rectal Neoplasms | 9 | 2022 | 1125 | 0.970 |
Why?
|
Diverticulitis, Colonic | 2 | 2021 | 123 | 0.830 |
Why?
|
Intestinal Perforation | 2 | 2021 | 256 | 0.830 |
Why?
|
Colonic Neoplasms | 8 | 2022 | 2532 | 0.800 |
Why?
|
Photochemotherapy | 2 | 2018 | 829 | 0.790 |
Why?
|
HIV Seropositivity | 2 | 2017 | 897 | 0.750 |
Why?
|
Appendiceal Neoplasms | 1 | 2021 | 118 | 0.750 |
Why?
|
Carcinoma in Situ | 2 | 2016 | 820 | 0.670 |
Why?
|
Laparoscopy | 5 | 2022 | 1996 | 0.670 |
Why?
|
Precancerous Conditions | 4 | 2017 | 944 | 0.650 |
Why?
|
Colorectal Surgery | 1 | 2019 | 114 | 0.620 |
Why?
|
Anal Canal | 2 | 2017 | 344 | 0.610 |
Why?
|
Colorectal Neoplasms | 7 | 2022 | 6590 | 0.590 |
Why?
|
Photosensitizing Agents | 2 | 2018 | 615 | 0.590 |
Why?
|
Hyperplasia | 3 | 2018 | 1173 | 0.580 |
Why?
|
Intestinal Obstruction | 1 | 2019 | 424 | 0.570 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2018 | 243 | 0.550 |
Why?
|
Arteriovenous Fistula | 1 | 2018 | 294 | 0.540 |
Why?
|
Catheter Ablation | 2 | 2017 | 2563 | 0.510 |
Why?
|
Colitis, Ulcerative | 3 | 2019 | 1814 | 0.460 |
Why?
|
Income | 1 | 2021 | 1805 | 0.450 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1062 | 0.440 |
Why?
|
Light Coagulation | 1 | 2011 | 73 | 0.440 |
Why?
|
Corneal Wavefront Aberration | 1 | 2010 | 6 | 0.400 |
Why?
|
HIV Seronegativity | 1 | 2011 | 207 | 0.400 |
Why?
|
Homosexuality, Male | 3 | 2017 | 1151 | 0.390 |
Why?
|
Infrared Rays | 1 | 2011 | 262 | 0.390 |
Why?
|
Health Expenditures | 2 | 2022 | 2266 | 0.390 |
Why?
|
Lasers, Excimer | 1 | 2010 | 76 | 0.380 |
Why?
|
Stromal Cells | 1 | 2015 | 1362 | 0.370 |
Why?
|
Keratomileusis, Laser In Situ | 1 | 2010 | 85 | 0.360 |
Why?
|
Adenocarcinoma | 6 | 2022 | 6370 | 0.350 |
Why?
|
Contact Lenses | 1 | 2010 | 150 | 0.350 |
Why?
|
Myopia | 1 | 2010 | 251 | 0.320 |
Why?
|
Anastomosis, Surgical | 3 | 2021 | 951 | 0.320 |
Why?
|
General Surgery | 1 | 2019 | 1652 | 0.310 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2020 | 8943 | 0.310 |
Why?
|
Colonic Polyps | 1 | 2011 | 521 | 0.300 |
Why?
|
Colon | 3 | 2020 | 1766 | 0.290 |
Why?
|
Colonoscopy | 3 | 2022 | 1315 | 0.280 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2274 | 0.270 |
Why?
|
Medicare | 1 | 2022 | 5787 | 0.270 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4038 | 0.250 |
Why?
|
Emergencies | 2 | 2019 | 1126 | 0.230 |
Why?
|
Neoadjuvant Therapy | 3 | 2022 | 2572 | 0.220 |
Why?
|
Retrospective Studies | 21 | 2022 | 72614 | 0.210 |
Why?
|
Colon, Transverse | 1 | 2021 | 22 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 5 | 2020 | 6778 | 0.210 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 78 | 0.210 |
Why?
|
Abdominal Abscess | 1 | 2022 | 146 | 0.200 |
Why?
|
New York | 2 | 2020 | 861 | 0.190 |
Why?
|
Abdomen, Acute | 1 | 2019 | 122 | 0.180 |
Why?
|
Cultural Competency | 1 | 2022 | 278 | 0.180 |
Why?
|
Diverticulitis | 1 | 2021 | 169 | 0.180 |
Why?
|
Proctoscopy | 1 | 2017 | 37 | 0.170 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2021 | 3564 | 0.170 |
Why?
|
Prognosis | 9 | 2022 | 29226 | 0.150 |
Why?
|
Treatment Refusal | 1 | 2020 | 421 | 0.150 |
Why?
|
Treatment Outcome | 8 | 2022 | 62348 | 0.150 |
Why?
|
Humans | 37 | 2022 | 717237 | 0.140 |
Why?
|
Rose Bengal | 1 | 2016 | 118 | 0.140 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2016 | 287 | 0.140 |
Why?
|
Appendicitis | 1 | 2022 | 635 | 0.140 |
Why?
|
Emigrants and Immigrants | 1 | 2021 | 482 | 0.140 |
Why?
|
Digestive System Surgical Procedures | 1 | 2020 | 569 | 0.140 |
Why?
|
Sus scrofa | 1 | 2016 | 455 | 0.130 |
Why?
|
Rectum | 1 | 2019 | 887 | 0.130 |
Why?
|
Aged | 11 | 2022 | 162856 | 0.130 |
Why?
|
Elasticity | 1 | 2016 | 658 | 0.130 |
Why?
|
Disease Progression | 1 | 2011 | 13307 | 0.130 |
Why?
|
Vascular Grafting | 1 | 2016 | 163 | 0.130 |
Why?
|
Middle Aged | 15 | 2021 | 215041 | 0.130 |
Why?
|
Neoplasm Staging | 7 | 2022 | 11200 | 0.130 |
Why?
|
Robotics | 1 | 2021 | 869 | 0.120 |
Why?
|
Saphenous Vein | 1 | 2016 | 518 | 0.120 |
Why?
|
Neoplasm Invasiveness | 4 | 2022 | 3704 | 0.120 |
Why?
|
Male | 18 | 2022 | 351380 | 0.120 |
Why?
|
Intestines | 1 | 2022 | 1932 | 0.120 |
Why?
|
Postoperative Complications | 4 | 2022 | 15126 | 0.110 |
Why?
|
Papillomavirus Infections | 2 | 2017 | 1515 | 0.110 |
Why?
|
Carotid Arteries | 1 | 2016 | 965 | 0.110 |
Why?
|
Demography | 1 | 2016 | 1624 | 0.110 |
Why?
|
Swine | 2 | 2022 | 5821 | 0.100 |
Why?
|
Disease-Free Survival | 3 | 2021 | 7056 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12483 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12417 | 0.090 |
Why?
|
Adult | 11 | 2021 | 212451 | 0.090 |
Why?
|
Bariatric Surgery | 1 | 2018 | 887 | 0.090 |
Why?
|
Refraction, Ocular | 1 | 2010 | 180 | 0.090 |
Why?
|
Health Status Disparities | 1 | 2021 | 1728 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2018 | 1091 | 0.090 |
Why?
|
Developing Countries | 1 | 2021 | 2732 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7177 | 0.080 |
Why?
|
Abscess | 2 | 2022 | 600 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 2942 | 0.080 |
Why?
|
Patient Care Team | 1 | 2019 | 2595 | 0.080 |
Why?
|
Female | 14 | 2021 | 377909 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39302 | 0.080 |
Why?
|
Crohn Disease | 1 | 2019 | 2255 | 0.080 |
Why?
|
Immunohistochemistry | 2 | 2022 | 11777 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8600 | 0.070 |
Why?
|
Pain, Postoperative | 1 | 2016 | 1633 | 0.070 |
Why?
|
Graft Survival | 1 | 2016 | 3765 | 0.070 |
Why?
|
Mass Screening | 1 | 2021 | 5213 | 0.070 |
Why?
|
Alphapapillomavirus | 1 | 2008 | 227 | 0.070 |
Why?
|
Young Adult | 4 | 2020 | 56247 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2022 | 7486 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3031 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2019 | 5141 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3565 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2015 | 1603 | 0.070 |
Why?
|
Pilot Projects | 1 | 2017 | 8066 | 0.070 |
Why?
|
Abdomen | 1 | 2009 | 1102 | 0.060 |
Why?
|
Length of Stay | 3 | 2022 | 6280 | 0.060 |
Why?
|
Logistic Models | 1 | 2019 | 13601 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2015 | 3243 | 0.060 |
Why?
|
United States | 5 | 2022 | 67798 | 0.060 |
Why?
|
Internship and Residency | 1 | 2022 | 5634 | 0.050 |
Why?
|
Stem Cells | 1 | 2015 | 3597 | 0.050 |
Why?
|
Survival Rate | 3 | 2020 | 13261 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2745 | 0.050 |
Why?
|
Visual Acuity | 1 | 2010 | 2502 | 0.050 |
Why?
|
Rats | 1 | 2018 | 25091 | 0.050 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3100 | 0.050 |
Why?
|
Colon, Sigmoid | 1 | 2020 | 114 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58528 | 0.050 |
Why?
|
Liver Cirrhosis | 1 | 2009 | 1751 | 0.050 |
Why?
|
RNA, Viral | 1 | 2008 | 2837 | 0.050 |
Why?
|
Adolescent | 4 | 2021 | 85139 | 0.040 |
Why?
|
Time Factors | 2 | 2011 | 41095 | 0.040 |
Why?
|
Appendectomy | 1 | 2022 | 388 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2015 | 20095 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18352 | 0.040 |
Why?
|
Emigration and Immigration | 1 | 2021 | 379 | 0.040 |
Why?
|
Developed Countries | 1 | 2021 | 403 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 12607 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23542 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2015 | 11758 | 0.040 |
Why?
|
Animals | 3 | 2022 | 170890 | 0.040 |
Why?
|
SEER Program | 1 | 2021 | 1576 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1621 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1287 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7847 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 20083 | 0.030 |
Why?
|
Prospective Studies | 1 | 2017 | 51275 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2975 | 0.030 |
Why?
|
Endoscopy | 1 | 2022 | 1758 | 0.030 |
Why?
|
Risk Factors | 2 | 2016 | 70864 | 0.030 |
Why?
|
Cost of Illness | 1 | 2021 | 1843 | 0.030 |
Why?
|
Cause of Death | 1 | 2020 | 3592 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2258 | 0.020 |
Why?
|
Overweight | 1 | 2021 | 2247 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 39887 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3403 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6099 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8923 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2019 | 3433 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 12923 | 0.020 |
Why?
|
Serum Albumin | 1 | 2009 | 682 | 0.020 |
Why?
|
Clinical Competence | 1 | 2022 | 4654 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 4872 | 0.020 |
Why?
|
Age Factors | 1 | 2020 | 18798 | 0.010 |
Why?
|
Diet | 1 | 2021 | 7565 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6294 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6753 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 34502 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14903 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 13274 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15271 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 16017 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 14896 | 0.010 |
Why?
|
Child | 1 | 2018 | 74387 | 0.010 |
Why?
|